Document is current
Any future updates will be listed below
-
Authors
Ramli, Fitri Fareez
Villa, Luca M.
Martens, Marieke A. G.
Singh, Nisha
Harmer, Catherine J.
Cowen, Philip J.
Godlewska, Beata R. https://orcid.org/0000-0002-5973-3765
-
Funding
Funding for this research was provided by:
UK Research and Innovation (MR/K022202)
University of Oxford
- License Information
-
More Information
Article History
Received: 14 February 2026
Accepted: 13 June 2026
First Online: 20 June 2026
Declarations
Competing interests: Nisha Singh holds a method-of-use patent (WO2012107735 A2) for ebselen in the treatment of bipolar disorder. Otherauthors declare no competing interests.
Ethical approval: The study was approved by the National Research Ethics Service Committee [NRES], South-Central Oxford [ID:20/SC/0151].
Informed consent: Informed consent was obtained from all participants before the study.
